Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-01-10 11:40 am Sale | 13G | COCRYSTAL PHARMA INC COCP | SABBY MANAGEMENT LLC | 420,710 11% | -5,317,410 (-92.67%) | View |
2023-01-10 11:21 am Sale | 13G | PULMATRIX INC PULM | SABBY MANAGEMENT LLC | 301,938 11% | -3,315,105 (-91.65%) | View |
2023-01-10 10:14 am Unchanged | 13G | REBUS HLDGS INC RBSH | SABBY MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
2023-01-04 09:21 am Purchase | 13G | BIONDVAX PHARMACEUTICALS LTD. BVXV | SABBY MANAGEMENT LLC | 228,329 11% | 228,329 (New Position) | View |
2023-01-04 09:09 am Purchase | 13G | REDHILL BIOPHARMA LTD RDHL | SABBY MANAGEMENT LLC | 7,540,400 11% | 7,540,400 (New Position) | View |
2023-01-04 09:01 am Purchase | 13G | TUANCHE LTD ADR TC | SABBY MANAGEMENT LLC | 2,384,713 11% | 2,384,713 (New Position) | View |
2023-01-04 08:49 am Purchase | 13G | HUADI INTL GROUP CO LTD USD HUDI | SABBY MANAGEMENT LLC | 1,422,494 11% | 1,422,494 (New Position) | View |
2023-01-04 08:40 am Purchase | 13G | KIROMIC BIOPHARMA INC KRBP | SABBY MANAGEMENT LLC | 1,822,847 11% | 1,822,847 (New Position) | View |
2023-01-04 08:33 am Purchase | 13G | QUANERGY SYS INC QNGY | SABBY MANAGEMENT LLC | 936,905 11% | 936,905 (New Position) | View |
2023-01-04 08:25 am Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | SABBY MANAGEMENT LLC | 264,000 11% | 264,000 (New Position) | View |
2023-01-04 08:10 am Purchase | 13G | BONE BIOLOGICS CORP BBLG | SABBY MANAGEMENT LLC | 1,237,205 11% | 1,237,205 (New Position) | View |
2023-01-04 08:00 am Sale | 13G | ADITXT INC ADTX | SABBY MANAGEMENT LLC | 415,697 11% | -1,755,200 (-80.85%) | View |
2023-01-04 07:49 am Purchase | 13G | NEPTUNE WELLNESS SOLUTIONS INC NEPT | SABBY MANAGEMENT LLC | 1,095,913 11% | 1,095,913 (New Position) | View |
2023-01-04 07:39 am Purchase | 13G | TOUGHBUILT INDS INC TBLT | SABBY MANAGEMENT LLC | 1,231,420 11% | 1,231,420 (New Position) | View |
2023-01-04 07:25 am Purchase | 13G | DOGNESS INTL CORP COM DOGZ | SABBY MANAGEMENT LLC | 2,078,783 11% | 2,078,783 (New Position) | View |
2023-01-04 07:13 am Purchase | 13G | BLUE WATER BIOTECH, INC BWV | SABBY MANAGEMENT LLC | 1,210,686 11% | 1,210,686 (New Position) | View |
2022-01-05 1:05 pm Purchase | 13G | SKYE BIOSCIENCE INC SKYE | SABBY MANAGEMENT LLC | 2,000,000 11% | 2,000,000 (New Position) | View |
2022-01-05 12:35 pm Sale | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | SABBY MANAGEMENT LLC | 0 0% | -904,710 (Position Closed) | View |
2022-01-05 12:29 pm Purchase | 13G | PULMATRIX INC PULM | SABBY MANAGEMENT LLC | 3,617,043 11% | 1,641,734 (+83.11%) | View |
2022-01-04 9:59 pm Sale | 13G | SUPERCOM, LTD. SPCB | SABBY MANAGEMENT LLC | 1,121,886 11% | -358,114 (-24.20%) | View |